Clinical Trial Update: Treatment of Non Severe Hemophagocytosis Lymphohistiocytosis With ITACITINIB [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating ITACITINIB for adults with non-severe hemophagocytic lymphohistiocytosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophagocytic Lymphohistiocytosis

Drugs mentioned

• Itacitinib (itacitinib)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Adults Patients Having Non Severe HLH | Phase 2 | Status: COMPLETED